Apriem Advisors Pfizer Inc Transaction History

Apriem Advisors

$849 Million
Q3 2024

A detailed history of Apriem Advisors transactions in Pfizer Inc stock. As of the latest transaction made, Apriem Advisors holds 58,700 shares of PFE stock, worth $1.57 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares

58,700

Previous 53,074 10.6%

Holding current value

$1.57 Million

Previous $1.49 Million 14.34%

% of portfolio

0.2%

Previous 0.18%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$27.7 - $31.39 $155,840 - $176,600	5,626 Added 10.6%	58,700 $1.7 Million
Q2 2024 Aug 14, 2024	BUY	$25.26 - $29.6 $12,099 - $14,178	479 Added 0.91%	53,074 $1.49 Million
Q1 2024 May 15, 2024	SELL	$25.89 - $29.73 $224,673 - $257,996	-8,678 Reduced 14.16%	52,595 $1.46 Million
Q4 2023 Feb 14, 2024	SELL	$26.13 - $33.94 $82,387 - $107,012	-3,153 Reduced 4.89%	61,273 $1.76 Million
Q3 2023 Nov 13, 2023	SELL	$32.09 - $37.51 $12,354 - $14,441	-385 Reduced 0.59%	64,426 $2.14 Million
Q2 2023 Aug 08, 2023	SELL	$36.12 - $41.79 $3,900 - $4,513	-108 Reduced 0.17%	64,811 $2.38 Million
Q1 2023 May 12, 2023	BUY	$39.39 - $51.28 $41,477 - $53,997	1,053 Added 1.65%	64,919 $2.65 Million
Q4 2022 Feb 13, 2023	SELL	$41.75 - $54.5 $40,205 - $52,483	-963 Reduced 1.49%	63,866 $3.27 Million
Q3 2022 Nov 14, 2022	SELL	$43.76 - $53.42 $73,210 - $89,371	-1,673 Reduced 2.52%	64,829 $2.84 Million
Q2 2022 Aug 08, 2022	SELL	$46.53 - $55.17 $459,251 - $544,527	-9,870 Reduced 12.92%	66,502 $3.49 Million
Q1 2022 May 10, 2022	SELL	$45.75 - $56.69 $555,359 - $688,159	-12,139 Reduced 13.71%	76,372 $3.95 Million
Q4 2021 Feb 09, 2022	SELL	$41.32 - $61.25 $714,877 - $1.06 Million	-17,301 Reduced 16.35%	88,511 $5.23 Million
Q3 2021 Nov 12, 2021	BUY	$39.25 - $50.42 $4,160 - $5,344	106 Added 0.1%	105,812 $4.55 Million
Q2 2021 Aug 10, 2021	SELL	$35.91 - $40.68 $37,418 - $42,388	-1,042 Reduced 0.98%	105,706 $4.14 Million
Q1 2021 May 10, 2021	BUY	$33.49 - $37.77 $126,692 - $142,883	3,783 Added 3.67%	106,748 $3.87 Million
Q4 2020 Feb 04, 2021	SELL	$33.47 - $42.56 $465,166 - $591,498	-13,898 Reduced 11.89%	102,965 $3.79 Million
Q3 2020 Nov 10, 2020	SELL	$31.75 - $37.25 $67,056 - $78,672	-2,112 Reduced 1.78%	116,863 $4.29 Million
Q2 2020 Aug 07, 2020	SELL	$30.12 - $36.54 $10,361 - $12,569	-344 Reduced 0.29%	118,975 $3.89 Million
Q1 2020 May 07, 2020	SELL	$27.03 - $38.62 $2.04 Million - $2.91 Million	-75,411 Reduced 38.73%	119,319 $3.9 Million
Q4 2019 Feb 10, 2020	SELL	$32.92 - $37.36 $137,276 - $155,791	-4,170 Reduced 2.1%	194,730 $7.63 Million
Q3 2019 Nov 12, 2019	SELL	$32.49 - $42.13 $192,730 - $249,915	-5,932 Reduced 2.9%	198,900 $7.15 Million
Q2 2019 Aug 14, 2019	BUY	$36.98 - $41.52 $24,295 - $27,278	657 Added 0.32%	204,832 $8.87 Million
Q1 2019 May 15, 2019	BUY	$37.5 - $41.2 $75,300 - $82,729	2,008 Added 0.99%	204,175 $8.67 Million
Q4 2018 Feb 19, 2019	BUY	$38.47 - $43.86 $523,769 - $597,153	13,615 Added 7.22%	202,167 $8.83 Million
Q3 2018 Nov 14, 2018	SELL	$34.47 - $41.81 $118,818 - $144,119	-3,447 Reduced 1.8%	188,552 $8.31 Million
Q2 2018 Aug 14, 2018	SELL	$32.98 - $35.16 $105,601 - $112,582	-3,202 Reduced 1.64%	191,999 $6.97 Million
Q1 2018 May 11, 2018	BUY	$31.91 - $37.02 $124,959 - $144,970	3,916 Added 2.05%	195,201 $6.93 Million
Q4 2017 Feb 14, 2018	BUY	$33.26 - $35.29 $88,604 - $94,012	2,664 Added 1.41%	191,285 $6.93 Million
Q3 2017 Nov 14, 2017	BUY	$31.0 - $34.15 $5.85 Million - $6.44 Million	188,621	188,621 $6.73 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Apriem Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Apriem Advisors with notifications on news.

Account